Research graph
References from Identification of the key target profiles underlying the drugs of narrow therapeutic index for treating cancer and cardiovascular disease. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1002/cpt.28
10.1002/cpt.28 · External reference
10.1038/nrd3801
10.1038/nrd3801 · External reference
Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide
10.1007/s00228-015-1832-0 · 2015 · External reference
Dose recommendations for anticancer drugs in patients with renal or hepatic impairment
10.1016/s1470-2045(19)30145-7 · 2019 · External reference
Identification of drug-drug interactions using chemical interactions
10.2174/1574893611666160618094219 · 2017 · External reference
10.1016/j.ccell.2019.10.001
10.1016/j.ccell.2019.10.001 · External reference
Real-time and label-free detection of VKORC1 genes based on a magnetoelastic biosensor for warfarin therapy
10.1039/d0tb00354a · 2020 · External reference
10.1200/jco.19.02551
10.1200/jco.19.02551 · External reference
10.1038/nrd.2015.36
10.1038/nrd.2015.36 · External reference
10.1038/nrclinonc.2017.59
10.1038/nrclinonc.2017.59 · External reference
A simple model to solve a drug toxicity problem
10.1039/c8tx00261d · 2019 · External reference
10.2174/1574893615666191219094216
10.2174/1574893615666191219094216 · External reference
10.1517/13543784.2012.632408
10.1517/13543784.2012.632408 · External reference
Heparin-binding protein: a novel biomarker linking four different cardiovascular diseases
2020 · External reference
A comparative study of disease genes and drug targets in the human protein interactome
10.1186/1471-2105-16-s5-s1 · 2015 · External reference
Fractionated dosing improves preclinical therapeutic index of pyrrolobenzodiazepine-containing antibody drug conjugates
10.1158/1078-0432.ccr-17-0219 · 2017 · External reference
Dose pptimization for anticancer drug combinations: maximizing therapeutic index via clinical exposure-toxicity/preclinical exposure-efficacy modeling
10.1158/1078-0432.ccr-18-3882 · 2019 · External reference
Predicting drug side effects with compact integration of heterogeneous networks
10.2174/1574893614666190220114644 · 2019 · External reference
A new construct of antibody-drug conjugates for treatment of B-cell non-Hodgkin's lymphomas
10.1016/j.ejps.2017.02.034 · 2017 · External reference
Determining the balance between drug efficacy and safety by the network and biological system profile of its therapeutic target
10.3389/fphar.2018.01245 · 2018 · External reference
Electrochemical and in silico approaches for liver metabolic oxidation of antitumor-active triazoloacridinone C-1305
10.1016/j.jpha.2020.03.011 · 2020 · External reference
Pharmacometric approach to define narrow therapeutic index (NTI) drugs & evaluate bioequivalence (BE) criteria for NTI drugs
2018 · External reference
Tyrosine kinase inhibiting the VEGF pathway and elderly people: Tolerance, pre-treatment assessment and side effects management
2016 · External reference
Prediction of intravenous busulfan clearance by endogenous plasma biomarkers using global pharmacometabolomics
10.1007/s11306-016-1106-6 · 2016 · External reference
Combination of capecitabine and phenytoin may cause phenytoin intoxication: a case report
10.1097/mjt.0b013e318293b10a · 2015 · External reference
Adaptive control methods for the dose individualisation of anticancer agents
10.2165/00003088-200038040-00003 · 2000 · External reference
Cisplatin and nifedipine: synergistic antitumor effects against an inherently cisplatin-resistant tumor
10.1016/0304-3835(88)90260-1 · 1988 · External reference
A 1000-fold overdose of clonidine caused by a compounding error in a 5-year-old child with attention-deficit/hyperactivity disorder
10.1542/peds.108.2.471 · 2001 · External reference
Simultaneous quantification of cyclophosphamide and its active metabolite 4-hydroxycyclophosphamide in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry
10.1016/j.jchromb.2007.04.024 · 2007 · External reference
Convallatoxin: a new P-glycoprotein substrate
10.1016/j.ejphar.2014.09.031 · 2014 · External reference
Generic substitution: issues for problematic drugs
10.1097/00007611-200194010-00003 · 2001 · External reference
Standards of laboratory practice: cardiac drug monitoring. National academy of clinical biochemistry
10.1093/clinchem/44.5.1096 · 1998 · External reference
Pilot study to assess toxicity and pharmacokinetics of docetaxel in patients with metastatic breast cancer and impaired liver function secondary to hepatic metastases
10.1177/1078155213480536 · 2014 · External reference
Inhibitory effects of limonin on six human cytochrome P450 enzymes and P-glycoprotein in vitro
10.1016/j.tiv.2011.09.023 · 2011 · External reference
Epinephrine (adrenaline) in the first-aid, out-of-hospital treatment of anaphylaxis
10.1002/0470861193.ch19 · 2004 · External reference
10.1200/jco.1986.4.3.425
10.1200/jco.1986.4.3.425 · External reference
Pharmaceutical and pharmacological approaches for bioavailability enhancement of etoposide
10.1007/s12038-013-9399-3 · 2014 · External reference
Optimizing everolimus exposure when combined with calcineurin inhibitors in solid organ transplantation
10.1016/j.trre.2017.02.007 · 2017 · External reference
Clinical pharmacokinetic and pharmacodynamic profile of cinacalcet hydrochloride
10.2165/00003088-200948050-00002 · 2009 · External reference
Benefit of uridine triacetate (vistogard) in rescuing severe 5-fluorouracil toxicity in patients with dihydropyrimidine dehydrogenase (DPYD) deficiency
10.1007/s00280-016-3063-1 · 2016 · External reference
Management of thrombotic and cardiovascular disorders in the new millenium
10.1177/107602960300900202 · 2003 · External reference
Oncolytic viral therapy using reovirus
10.1007/978-1-4939-2727-2_12 · 2015 · External reference
Toxic death case in a patient undergoing gemcitabine-based chemotherapy in relation with cytidine deaminase downregulation
10.1097/fpc.0b013e32825ea6e3 · 2007 · External reference
Targeting attenuated interferon-alpha to myeloma cells with a CD38 antibody induces potent tumor regression with reduced off-target activity
10.1371/journal.pone.0162472 · 2016 · External reference
Pharmacokinetic optimisation of drug therapy in elderly patients
10.2165/00002512-199507010-00002 · 1995 · External reference
10.1007/s00228-008-0478-6
10.1007/s00228-008-0478-6 · External reference
Variability of mitomycin C adsorption by activated charcoal
10.1111/j.2042-7158.1998.tb06857.x · 1998 · External reference
Effects of adrenolytic mitotane on drug elimination pathways assessed in vitro
10.1007/s12020-014-0517-2 · 2015 · External reference
Capecitabine and oxaliplatin (XELOX) for the treatment of patients with metastatic gastric cancer and severe liver dysfunction
10.3904/kjim.2006.21.4.252 · 2006 · External reference
Prevalence of CYP2C8 polymorphisms in a North Indian population
10.4238/2013.july.8.7 · 2013 · External reference
Prediction of renal transporter mediated drug-drug interactions for pemetrexed using physiologically based pharmacokinetic modeling
10.1124/dmd.114.059618 · 2015 · External reference
Advancement in antithrombotics for stroke prevention in atrial fibrillation
10.1007/s10840-008-9210-9 · 2008 · External reference
Herbal remedies: drug-herb interactions
10.4037/ccn2002.22.2.22 · 2002 · External reference
10.1517/17425255.2014.885016
10.1517/17425255.2014.885016 · External reference
Phase I-II vinorelbine (navelbine) by continuous infusion in patients with metastatic breast cancer: cumulative toxicities limit dose escalation
10.1081/cnv-100103844 · 2001 · External reference
2012 FDA drug approvals
10.1038/nrd3946 · 2013 · External reference
Overdose of aripiprazole, a new type of antipsychotic
10.1016/j.jemermed.2004.09.013 · 2005 · External reference
Nonstimulant treatment of adult attention-deficit/hyperactivity disorder
10.1016/j.psc.2003.12.001 · 2004 · External reference
2011 FDA drug approvals
10.1038/nrd3657 · 2012 · External reference
Biowaiver monographs for immediate-release solid oral dosage forms: enalapril
10.1016/j.xphs.2017.04.019 · 2017 · External reference
Side effects of antiepileptics–a review
10.1111/j.1533-2500.2004.04304.x · 2004 · External reference
2008 FDA drug approvals
10.1038/nrd2813 · 2009 · External reference
Biowaiver monographs for immediate release solid oral dosage forms: lamivudine
10.1002/jps.22449 · 2011 · External reference
Clinical pharmacokinetics and pharmacodynamics of linagliptin
10.2165/11630900-000000000-00000 · 2012 · External reference
Chemotherapy dosing in the setting of liver dysfunction
2005 · External reference
Mitoxantrone: an active, new antitumor agent with an improved therapeutic index
10.1016/0305-7372(87)90021-1 · 1987 · External reference
Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years
10.1542/peds.108.3.e48 · 2001 · External reference
Elidel (pimecrolimus) cream 1%: a nonsteroidal topical agent for the treatment of atopic dermatitis
10.1067/mai.2003.1492 · 2003 · External reference
Unresolved reference
External reference
Effects of rolapitant administered intravenously or orally on the pharmacokinetics of digoxin (P-glycoprotein substrate) and sulfasalazine (breast cancer resistance protein substrate) in healthy volunteers
10.1002/jcph.1005 · 2018 · External reference
2009 FDA drug approvals
10.1038/nrd3101 · 2010 · External reference
ClinicalTrials.gov and Drugs@FDA: a comparison of results reporting for new drug approval trials
10.7326/m15-2658 · 2016 · External reference
ICD-11
10.1016/s0140-6736(19)31205-x · 2019 · External reference
Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics
2020 · External reference
10.1093/nar/gky1131
10.1093/nar/gky1131 · External reference
Graph theoretic network analysis reveals protein pathways underlying cell death following neurotropic viral infection
10.1038/srep14438 · 2015 · External reference
Hyaluronic acid-tagged silica nanoparticles in colon cancer therapy: therapeutic efficacy evaluation
2015 · External reference
A protein network descriptor server and its use in studying protein, disease, metabolic and drug targeted networks
2017 · External reference
10.1101/gr.1239303
10.1101/gr.1239303 · External reference
10.1186/1479-7364-4-5-353
10.1186/1479-7364-4-5-353 · External reference
10.1093/nar/gkaa970
10.1093/nar/gkaa970 · External reference
10.1007/s00214-009-0670-5
10.1007/s00214-009-0670-5 · External reference
10.1093/nar/gky1049
10.1093/nar/gky1049 · External reference
10.1124/pr.58.2.4
10.1124/pr.58.2.4 · External reference
10.1124/jpet.108.149955
10.1124/jpet.108.149955 · External reference
Development of expressed sequence tags from the bay scallop
10.1007/s10126-005-0126-4 · 2006 · External reference
Choke point analysis of metabolic pathways in E.histolytica: a computational approach for drug target identification
10.6026/97320630002068 · 2007 · External reference
10.1093/nar/gkz779
10.1093/nar/gkz779 · External reference
10.1093/nar/gkaa755
10.1093/nar/gkaa755 · External reference
Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics
10.1093/nar/gkx1076 · 2018 · External reference
10.1093/nar/gks1193
10.1093/nar/gks1193 · External reference
10.1016/j.coph.2013.05.009
10.1016/j.coph.2013.05.009 · External reference
10.1093/nar/gkr284
10.1093/nar/gkr284 · External reference
10.1155/2016/2509385
10.1155/2016/2509385 · External reference
Clinical trials, progression-speed differentiating features and swiftness rule of the innovative targets of first-in-class drugs
10.1093/bib/bby130 · 2020 · External reference
ADReCS-Target: target profiles for aiding drug safety research and application
10.1093/nar/gkx899 · 2018 · External reference
10.1016/j.semcancer.2019.12.011
10.1016/j.semcancer.2019.12.011 · External reference
Identification of novel key targets and candidate drugs in oral squamous cell carcinoma
10.2174/1574893614666191127101836 · 2020 · External reference
Consistent gene signature of schizophrenia identified by a novel feature selection strategy from comprehensive sets of transcriptomic data
10.1093/bib/bbz049 · 2020 · External reference
ANPELA: analysis and performance assessment of the label-free quantification workflow for metaproteomic studies
10.1093/bib/bby127 · 2020 · External reference
NOREVA: enhanced normalization and evaluation of time-course and multi-class metabolomic data
10.1093/nar/gkaa258 · 2020 · External reference
10.1146/annurev-pharmtox-010919-023746
10.1146/annurev-pharmtox-010919-023746 · External reference
MetaFS: Performance assessment of biomarker discovery in metaproteomics
2020 · External reference
Application of artificial intelligence using a novel EUS-based convolutional neural network model to identify and distinguish benign and malignant hepatic masses
2020 · External reference
APP medical diagnostic check-up consultation system based on speech recognition
10.2174/1574893614666191105161335 · 2020 · External reference
Simultaneous improvement in the precision, accuracy, and robustness of label-free proteome quantification by optimizing data manipulation chains
10.1074/mcp.ra118.001169 · 2019 · External reference
10.2174/1574893614666191104160927
10.2174/1574893614666191104160927 · External reference
What contributes to serotonin-norepinephrine reuptake inhibitors' dual-targeting mechanism? The key role of transmembrane domain 6 in human serotonin and norepinephrine transporters revealed by molecular dynamics simulation
10.1021/acschemneuro.7b00490 · 2018 · External reference
SSizer: determining the sample sufficiency for comparative biological study
10.1016/j.jmb.2020.01.027 · 2020 · External reference
Deep learning predictions of survival based on MRI in amyotrophic lateral sclerosis
10.1016/j.nicl.2016.10.008 · 2017 · External reference
DeepFam: deep learning based alignment-free method for protein family modeling and prediction
10.1093/bioinformatics/bty275 · 2018 · External reference
Predicting drug-target interactions via FM-DNN learning
2020 · External reference
10.1016/j.jacc.2017.03.571
10.1016/j.jacc.2017.03.571 · External reference
Robustness of random forest-based gene selection methods
10.1186/1471-2105-15-8 · 2014 · External reference
Computational identification of binding energy hot spots in protein-RNA complexes using an ensemble approach
10.1093/bioinformatics/btx822 · 2018 · External reference
Evaluation of variable selection methods for random forests and omics data sets
10.1093/bib/bbx124 · 2019 · External reference
10.1016/j.csbj.2020.07.009 · Admitted local publication
10.1021/acs.analchem.7b02389
10.1021/acs.analchem.7b02389 · External reference
Expression profile and specific network features of the apoptotic machinery explain relapse of acute myeloid leukemia after chemotherapy
10.1186/1471-2407-10-377 · 2010 · External reference
Identifying potential quality markers of Xin-Su-Ning capsules acting on arrhythmia by integrating UHPLC-LTQ-orbitrap, ADME prediction and network target analysis
10.1016/j.phymed.2018.01.019 · 2018 · External reference
Pharmacophore mapping of ligand based virtual screening, molecular docking and molecular dynamic simulation studies for finding potent NS2B/NS3 protease inhibitors as potential anti-dengue drug compounds
10.2174/1574893613666180118105659 · 2018 · External reference
10.1038/ismej.2015.261
10.1038/ismej.2015.261 · External reference
10.1371/journal.pone.0060618
10.1371/journal.pone.0060618 · External reference
10.1039/c0mb00249f
10.1039/c0mb00249f · External reference
Network pharmacology: exploring the resources and methodologies
10.2174/1568026618666180330141351 · 2018 · External reference
10.1093/bioinformatics/btt131
10.1093/bioinformatics/btt131 · External reference
10.1038/nbt.3001
10.1038/nbt.3001 · External reference
10.1093/bioinformatics/btp517
10.1093/bioinformatics/btp517 · External reference
Predicting candidate genes based on combined network topological features: a case study in coronary artery disease
10.1371/journal.pone.0039542 · 2012 · External reference
Neighbours of cancer-related proteins have key influence on pathogenesis and could increase the drug target space for anticancer therapies
10.1038/s41540-017-0003-6 · 2017 · External reference
10.1371/journal.pcbi.1000601
10.1371/journal.pcbi.1000601 · External reference
The local triangle structure centrality method to rank nodes in networks
2019 · External reference
k-Skip-n-Gram-RF: a random forest based method for alzheimer's disease protein identification
10.3389/fgene.2019.00033 · 2019 · External reference
Understanding the influence of all nodes in a network
10.1038/srep08665 · 2015 · External reference
10.1016/j.jmb.2016.10.013
10.1016/j.jmb.2016.10.013 · External reference
10.1016/j.neuroimage.2009.10.003
10.1016/j.neuroimage.2009.10.003 · External reference
A phase II study of mitoxantrone in advanced squamous cell cancer of the head and neck
10.1007/bf00216935 · 1990 · External reference
10.1038/35075138
10.1038/35075138 · External reference
10.1038/nrg1272
10.1038/nrg1272 · External reference
Is the average shortest path length of gene set a reflection of their biological relatedness?
10.1142/s0219720016600027 · 2016 · External reference
